本报讯(记者矫月)近日，港交所主板上市企业美中嘉和医学技术发展集团股份有限公司(以下简称“美中嘉和”)发布盈利预警公告。公告显示，公司预计2026年上半年实现收入2.6亿元至2.8亿元(人民币)，同比增长29%至39%；毛利润6300万元至8300万元(人民币)，同比增长16349%至21571%。业内人士分析，公司毛利的大幅改善，也意味着美中嘉和多年投入建设的质子治疗中心开始进入规模化运营阶段，...
Source Link本报讯(记者矫月)近日，港交所主板上市企业美中嘉和医学技术发展集团股份有限公司(以下简称“美中嘉和”)发布盈利预警公告。公告显示，公司预计2026年上半年实现收入2.6亿元至2.8亿元(人民币)，同比增长29%至39%；毛利润6300万元至8300万元(人民币)，同比增长16349%至21571%。业内人士分析，公司毛利的大幅改善，也意味着美中嘉和多年投入建设的质子治疗中心开始进入规模化运营阶段，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.